Rapid Communication
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 28, 2006; 12(8): 1281-1286
Published online Feb 28, 2006. doi: 10.3748/wjg.v12.i8.1281
Table 1 Prevalence of each type of gallstone disease among 2386 Chinese subjects
VariableGallstone disease
TotalscreenednumberSingle stoneprevalencenumber(%)Multiple stonesprevalencenumber(%)Cholecystectomyprevalencenumber(%)
Gender
Male123521(1.7)21(1.7)17(1.4)
Female115119(1.7)34(3.0)14(1.2)
P-value for χ2-test0.950.040.76
Age
<407454(0.5)5(0.7)2(0.3)
40-497236(0.8)7(1.0)6(0.8)
50-5950411(2.2)21(4.2)8(1.6)
60-692527(2.8)17(6.8)6(2.4)
70+16212(7.4)5(3.1)9(5.6)
P-value for Cochran-Armitage trend test<0.0001<0.0001<0.0001
Total238640(1.7)55(2.3)31(1.3)
Table 2 Comparison of characteristics in subjects with and without gallstone disease
VariableAny type of gallstone disease
Yes(n=126)Mean ± SDNo(n=2260)Mean ± SDTotal(n=2386)Mean ± SDP-valuefor t test
Age (yr)58.63 ± 13.0446.57 ± 13.2247.21 ± 13.48<0.0001
BMI (kg/m2)24.83 ± 3.6423.50 ± 3.5523.57 ± 3.57<0.0001
FPG (mg/dL)109.22 ± 33.2196.98 ± 25.2197.63 ± 25.84<0.0001
SBP (mmHg)130.06 ± 20.07122.55 ± 18.40122.94 ± 18.56<0.0001
DBP (mmHg)81.27 ± 12.2279.56 ± 12.5679.65 ± 12.550.14
Cholesterol (mg/dL)216.93 ± 41.06210.51 ± 37.72210.87 ± 37.940.07
Triglyceride (mg/dL)143.39 ± 98.63130.12 ± 108.06130.86 ± 107.580.18
HDL (mg/dL)57.02 ± 16.5557.69 ± 15.7657.65 ± 15.800.64
BUN (mg/dL)14.94 ± 6.2813.55 ± 5.5613.63 ± 5.610.02
Creatinine (mg/dL)1.08 ± 0.351.04 ± 0.401.04 ± 0.400.29
Uric acid (mg/dL)6.74 ± 1.676.59 ± 1.726.60 ± 1.720.35
AST (U/L)32.79 ± 30.1327.59 ± 17.5927.88 ± 18.540.06
ALT (U/L)37.84 ± 54.2730.01 ± 34.4930.45 ± 35.910.11
Table 3 Univariate analysis of associated clinical factors for gallstone disease among 2386 Chinese subjects
Gallstone disease
Crude OR(95% CI)Adjusted OR1(95% CI)
Yes(n=126)No(n=2260)
Gendermale5911761.00-
female6710841.23(0.86-1.76)
Age (yr)<40117341.00-
40-49197041.80 (0.85-3.81)-
50-59404645.75(2.92-11.32)-
60-69302229.02(4.45-18.29)-
≥702613612.76(6.16-26.43)-
BMI (Kg/m2)<245713431.001.00
24-27385851.53(1.00-2.33)1.36(0.88-2.10)
≥2731332.20(1.40-3.46)2.04(1.28-3.26)
FPG (mg/dL)<1109320071.001.00
110-125101221.77(0.90-3.49)1.14(0.57-2.28)
≥126231263.95(2.42-6.45)1.95(1.16-3.30)
High SBPNo9318851.001.00
Yes333751.78(1.18-2.69)1.18(0.54-1.33)
High DBPNo9718011.001.00
Yes294591.17(0.77-1.80)0.95(0.61-1.48)
Hypercholeste-rolemiaNo9318271.001.00
Yes334331.50(1.00-2.26)1.11(0.72-1.69)
Hypertriglycer-idemiaNo10019461.001.00
Yes263141.61(1.03-2.52)1.54(0.97-2.46)
Low HDLNo12220521.001.00
Yes42080.32(0.12-0.89)0.62(0.22-1.73)
High BUNNo11521181.001.00
Yes111421.43(0.75-2.71)0.67(0.34-1.33)
High creatinineNo11822141.001.00
Yes8463.26(1.51-7.07)1.22(0.54-2.78)
HyperuricemiaNo439631.001.00
Yes8312971.43(0.98-2.09)1.18(0.80-1.75)
Higher ASTNo10620951.001.00
Yes201652.40(1.45-3.97)1.96(1.16-3.32)
Higher ALTNo10118831.001.00
Yes253771.24(0.79-1.94)1.48(0.92-2.37)
HBVNegative11319751.001.00
Positive132850.80(0.44-1.43)0.98(0.54-1.78)
Anti-HCVNegative12322041.001.00
Positive3560.96(0.30-3.11)0.63(0.19-2.07)
Table 4 Multiple logistic regression of associated factors for gallstone disease among 2386 Chinese subjects
VariableGallstone disease(yes vs no)
 OR95%CI
Gender (female vs male)1.340.90-1.99
Age(40-49 vs <40 yr)1.630.76-3.48
(50-59 vs <40 yr)4.932.43-9.99
(60-69 vs <40 yr)6.823.19-14.60
(≥70 vs <40 yr)10.654.78-23.73
BMI(24-27 vs <24 kg/m2)1.250.79-1.97
(≥27 vs <24 kg/m2)1.741.04-2.88
FPG(110-125 vs <110 mg/dL)0.960.47-1.97
(≥126 vs <110 mg/dL)1.711.01-2.96
High SBP (yes vs no)1.110.53-1.51
High DBP (yes vs no)0.870.52-1.48
Hypercholesterolemia (yes vs no)0.990.64-1.53
Hypertriglyceridemia (yes vs no)1.250.75-2.08
Low HDL (yes vs no)0.50.17-1.44
High BUN (yes vs no)0.590.26-1.37
High creatinine (yes vs no)2.020.71-5.75
Hyperuricemia (yes vs no)0.970.64-1.46
Higher AST (yes vs no)2.060.99-4.31
Higher ALT (yes vs no)0.830.42-1.63
HBV (positive vs negative)0.950.52-1.76
Anti-HCV (positive vs negative)0.50.15-1.69